Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease-Reference-Cited by-同舟云学术

Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease

Published:2019-09-30 Issue:10 Volume:15 Page:1009-1017
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Distler Oliver¹,Volkmann Elizabeth R.²,Hoffmann-Vold Anna Maria³,Maher Toby M.⁴

Affiliation:

1. Department of Rheumatology, University Hospital, Zurich, Switzerland

2. Department of Medicine, Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

3. Department of Rheumatology, Oslo University Hospital, Oslo, Norway

4. National Institute for Health Research Respiratory Clinical Research Facility, Royal Brompton and Harefield NHS Foundation Trust, and Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK

Funder

Boehringer Ingelheim

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2020.1668269

Reference82 articles.

1. Systemic sclerosis

2. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

3. The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target

4. Classification of systemic sclerosis. Visions and reality**Dedicated to the memory of E. Carwile LeRoy, 1933–2002.

5. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis;Rheumatology;2024-07-22

2. The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database;Diagnostics;2024-01-30

3. Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort;RMD Open;2024-01

4. Progressive Interstitial Lung Disease Non-Responsive to Immunosuppressive Therapy;Scleroderma;2024

5. Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis;Rheumatology;2023-04-19